Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial

Yan Zhao, Bo Chen, Bin Yang et al.|Chinese Medical Journal|2023

Cited by 40